Is loss of power output due to laser fiber degradation still an issue during prostate vaporization using the 180 W GreenLight XPS laser?

[1]  S. Shariat,et al.  Long-term follow-up data more than 5 years after surgical management of benign prostate obstruction: who stands the test of time? , 2016, Current opinion in urology.

[2]  F. Bruyère,et al.  A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study. , 2016, European urology.

[3]  H. Woo,et al.  A systematic review of experience of 180‐W XPS GreenLight laser vaporisation of the prostate in 1640 men , 2015, BJU international.

[4]  F. Bruyère,et al.  A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. , 2015, The Journal of urology.

[5]  A. Bachmann,et al.  Update on Greenlight laser vaporization (PVP) 2014 , 2015, World Journal of Urology.

[6]  R. Schmidt,et al.  The 532-nm 180-W (GreenLight®) laser vaporization of the prostate for the treatment of lower urinary tract symptoms: how durable is the new side-fire fiber with integrated cooling system? , 2014, Lasers in Medical Science.

[7]  T. Hermanns,et al.  Prospective evaluation of irrigation fluid absorption during pure transurethral bipolar plasma vaporisation of the prostate using expired‐breath ethanol measurements , 2013, BJU international.

[8]  Alexander Bachmann,et al.  EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. , 2013, European urology.

[9]  U. Nagele,et al.  EAU guidelines on laser technologies. , 2012, European urology.

[10]  H. Woo,et al.  180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. , 2012, European urology.

[11]  C. Iselin,et al.  High‐power potassium‐titanyl‐phosphate laser fibres for endovaporization of benign prostatic hyperplasia: how much do they deteriorate during the procedure? , 2011, BJU international.

[12]  T. Hermanns,et al.  Lithium triborate laser vaporization of the prostate using the 120 W, high performance system laser: high performance all the way? , 2009, The Journal of urology.

[13]  T. Hermanns,et al.  Laser fibre deterioration and loss of power output during photo-selective 80-w potassium-titanyl-phosphate laser vaporisation of the prostate. , 2009, European urology.

[14]  Thorsten Bach,et al.  Technical aspects of lasers in urology , 2007, World Journal of Urology.

[15]  G. Muir,et al.  Photoselective vaporization of the prostate (GreenLight PV): lessons learnt after 3500 procedures , 2007, Prostate Cancer and Prostatic Diseases.

[16]  A. Te,et al.  The Next Generation in Laser Treatments and the Role of the GreenLight High-Performance System Laser. , 2006, Reviews in urology.

[17]  O. Reich,et al.  Photoselective vaporization of the prostate: the basel experience after 108 procedures. , 2005, European urology.

[18]  A. Te,et al.  The development of laser prostatectomy , 2004, BJU international.

[19]  R. Malek,et al.  Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. , 2003, Journal of endourology.

[20]  D. M. Barrett,et al.  High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. , 1998, Urology.

[21]  C. Fowler,et al.  A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. , 1995, Urology.

[22]  B Stein,et al.  A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. , 1995, Urology.